1. Hahn B.H., Pletscher L.S., Muniain M. 1981: Immunosuppressive effects of deflazacort — a new glucocorticoid with bone-sparing and carbohydrate-sparing properties: comparison with prednisolone. J. Rheumatol., 8, 783–790.
2. Guenther H.L., Felix R., Fleisch H. 1984: Comparative study of deflazacort and dexamethasone on the synthesis of collagen by different bone cell populations and chondrocytes. Calcif. Tissue Int., 36, 145–152.
3. Pagano G., Lombardi A., Ferraris G.M., Imbimbo B., Carvallo P.P. 1982: Acute effect of prednisolone and deflazacort on glucose tolerance in prediabetic subjects. Eur. J. Clin. Pharmacol., 22, 469–471.
4. Martinelli E., Ferrari P., Ripamonti A., Tuan G., Perazzi A., Assandro A. 1979: Metabolism of deflazacort in the rat, dog and man, Drug Metab. Dispos., 7, 335–339.
5. Canali S., Assandri A., Giachetti C., Zanolo G., Imbimbo B. 1990: Absolute oral bioavailability of deflazacort (Flantadin®) in the healthy volunteer, Eur. J. Drug Metab. Dispos., 15 (Suppl.), 14.